These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8962399)

  • 1. Prognostic value of eosinophils for therapeutic response in severe acute hepatic allograft rejection.
    Ben-Ari Z; Dhillon AP; Garwood L; Rolles K; Davidson B; Burroughs AK
    Transplant Proc; 1996 Dec; 28(6):3624-8. PubMed ID: 8962399
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and immunological aspects of liver allograft rejection.
    Schlitt HJ
    Transplant Proc; 1996 Feb; 28(1):514-6. PubMed ID: 8644333
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
    Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
    [No Abstract]   [Full Text] [Related]  

  • 4. FK 506 used as rescue therapy for refractory liver allograft rejection.
    Chen CL; Eng HL; Chen YS; Kuo YC; Sun CK
    Transplant Proc; 1994 Aug; 26(4):1927-9. PubMed ID: 7520612
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
    Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
    Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
    [No Abstract]   [Full Text] [Related]  

  • 6. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
    Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
    [No Abstract]   [Full Text] [Related]  

  • 7. Low incidence of chronic rejection in patients experiencing histological acute rejection without simultaneous impairment in liver function tests.
    Farges O; Nocci Kalil A; Sebagh M; Reynes M; Bismuth H
    Transplant Proc; 1995 Feb; 27(1):1142-3. PubMed ID: 7878827
    [No Abstract]   [Full Text] [Related]  

  • 8. Proliferation rate of cells in the interstitial infiltrate in acute kidney allograft rejection.
    Olsen S; Hansen HE
    Transplant Proc; 1996 Feb; 28(1):502-3. PubMed ID: 8644329
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience in therapy of chronic liver allograft rejection.
    Charco R; Ruiz C; Allende E; Balsells J; Lazaro JL; Murio E; Bilbao I; Gifre E; Margarit C
    Transplant Proc; 1995 Aug; 27(4):2293-4. PubMed ID: 7652811
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver allograft rejection: analysis of OKT3 rescue therapy.
    McCaughan GW; Strasser S; Dolan P; Sheil AG
    Transplant Proc; 1992 Oct; 24(5):2250-1. PubMed ID: 1413044
    [No Abstract]   [Full Text] [Related]  

  • 11. The significance of eosinophils in mild and moderate acute cardiac allograft rejection.
    Gollub SB; Huntrakoon M; Dunn MI
    Am J Cardiovasc Pathol; 1990; 3(1):21-6. PubMed ID: 2331359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation from cadaveric and living donors.
    Lo CM; Lo RJ; Lai CL; Fan ST; Wong J
    Transplant Proc; 1996 Jun; 28(3):1659-60. PubMed ID: 8658826
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and patterns of rejection using different induction therapies in liver transplant recipients.
    Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G
    Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
    McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
    Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory acute rejection in a living related liver transplantation.
    Noritomi T; Sugawara Y; Kaneko J; Matsui Y; Makuuchi M
    Hepatogastroenterology; 2003; 50(54):2192-3. PubMed ID: 14696495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophils in acute renal allograft rejection.
    Hongwei W; Nanra RS; Stein A; Avis L; Price A; Hibberd AD
    Transpl Immunol; 1994; 2(1):41-6. PubMed ID: 8081790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients.
    Stephens J; Goldstein R; Crippin J; Husberg B; Holman M; Gonwa TA; Klintmalm G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1122-3. PubMed ID: 7680144
    [No Abstract]   [Full Text] [Related]  

  • 18. [OKT3 treatment of refractory renal allograft rejection].
    Xu J; Ma J; Bai X
    Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):223-5. PubMed ID: 10374543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine levels in the early posttransplant period: predictive of chronic rejection in liver transplantation?
    Soin AS; Rasmussen A; Jamieson NV; Tokat Y; Watson CJ; Friend PJ; Wight DG; Calne RY
    Transplant Proc; 1995 Feb; 27(1):1129-30. PubMed ID: 7878821
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.